These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3575746)
21. [New prospects in the study of the relations between hypertension and atherosclerosis]. Eliseev OM Ter Arkh; 1994; 66(4):71-6. PubMed ID: 8016737 [No Abstract] [Full Text] [Related]
22. Drug therapy for dyslipoproteinaemia. Bain SC; Barnett AH; Jones AF Diabet Med; 1990 Dec; 7(10):931-4. PubMed ID: 2149695 [No Abstract] [Full Text] [Related]
24. [Atheroma and heterogeneity of lipoproteins: the medical aspect]. Douste-Blazy P; Chollet F; Perret B; Chap H; Douste-Blazy L Ann Biol Clin (Paris); 1986; 44(4):353-60. PubMed ID: 3538950 [No Abstract] [Full Text] [Related]
25. [Hyperlipoproteinemia, a factor of severity in acute pancreatitis]. Mircea N; Constantinescu C; Jianu E; Buşu G; Ene C; Nedelcu A; Vrejoiu G; Daşchievici S; Struja D; Ungureanu D; Horvat D Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1981; 30(4):257-65. PubMed ID: 6460273 [TBL] [Abstract][Full Text] [Related]
26. [Changes in lipoprotein metabolism. III. Treatment]. Sienra Pérez JC; Posadas Romero C Arch Inst Cardiol Mex; 1991; 61(3):267-77. PubMed ID: 1929676 [No Abstract] [Full Text] [Related]
27. Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin. Glueck CJ; Fallat R; Tsang R Pediatrics; 1973 Nov; 52(5):669-79. PubMed ID: 4355362 [No Abstract] [Full Text] [Related]
28. Drug therapy for diabetic dyslipoproteinaemia: a practical approach. Winocour PH; Laker MF Diabet Med; 1990 May; 7(4):292-8. PubMed ID: 2140080 [No Abstract] [Full Text] [Related]
30. [Evaluation of a sulfomucopolysaccharide (3GS) in the treatment of hyperlipoproteinemias]. Palmieri G; Perego M; Nazzari M; Casalini F Clin Ter; 1982 Jun; 101(6):603-14. PubMed ID: 7128029 [No Abstract] [Full Text] [Related]
31. [Drug therapy of hyperlipoproteinemias]. Pometta D Ther Umsch; 1980 Feb; 37(2):110-3. PubMed ID: 7385076 [No Abstract] [Full Text] [Related]
34. [Effect of clofibrate therapy on serum lipids and lipoproteins]. Romics L; Szondy E; Gerö S Orv Hetil; 1980 Feb; 121(6):321-3. PubMed ID: 7366989 [No Abstract] [Full Text] [Related]
35. Postprandial lipemia: emerging evidence for atherogenicity of remnant lipoproteins. Cohn JS Can J Cardiol; 1998 May; 14 Suppl B():18B-27B. PubMed ID: 9627538 [TBL] [Abstract][Full Text] [Related]
36. [Possible approaches to the rational differentiation of diseases and syndromes combined under the heading "atherosclerosis"]. Avtsyn AP; Lempert BD Sov Med; 1981; (9):65-71. PubMed ID: 7031909 [No Abstract] [Full Text] [Related]
37. [Methods of biochemical analysis in hyperliproproteinemias]. Fruchart JC; Clavey V; Vanhoutte G Pathol Biol (Paris); 1983 Apr; 31(4):235-45. PubMed ID: 6408590 [TBL] [Abstract][Full Text] [Related]
38. Structure and function of plasma lipoproteins with particular regard to hyperlipoproteinemias and atherosclerosis. Alaupovic P Ann Biol Clin (Paris); 1980; 38(2):83-93. PubMed ID: 6992659 [No Abstract] [Full Text] [Related]